Menu
Back to Journals » Cancer Management and Research » Volume 11
RETRACTED ARTICLE: Isovitexin Suppresses Cancer Stemness Property And Induces Apoptosis Of Osteosarcoma Cells By Disruption Of The DNMT1/miR-34a/Bcl-2 Axis
Authors Liang X, Xu C, Cao X, Wang W
Received 10 July 2019
Accepted for publication 27 September 2019
Published 15 October 2019 Volume 2019:11 Pages 8923—8936
DOI https://doi.org/10.2147/CMAR.S222708
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Harikrishna Nakshatri
This paper has been retracted.
Liang X, Xu C, Cao X, Wang W. Cancer Manag Res. 2019;11:8923–8936.
We, the Editors and Publisher of Cancer Management and Research, have retracted the following article.
Since publication, concerns have been raised about the integrity of the data in the article. This includes the duplication of images from Figure 2 with images from another article. Specifically,
- The western blot image for Figure 2J, DNMT1, has been duplicated with the image for Figure 3h, CD44, from Liang X, Xu C, Wang W, Li X, The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells. Stem Cells Int. 2019;2019:7028901. https://doi.org/10.1155/2019/7028901.
When approached for an explanation, the authors did not respond to our queries, nor did they provide original data for their study. As the findings could not be verified the Editor and Publisher made the decision to retract the article and the authors were notified of this.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.